Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Medical Database Study on Automated Clinical Laboratory Decision Support System Published in the Interactive Journal of Medical Research
Healthcare & PharmaceuticalProduct Announcements

Medical Database Study on Automated Clinical Laboratory Decision Support System Published in the Interactive Journal of Medical Research

February 18, 2025 9:00 AM

Medical Database, Inc., a leader in providing innovative laboratory decision support tools, announces the publication of a new study on the Automated Clinical Laboratory Decision Support System (CDSS) in the Interactive Journal of Medical Research. The study, led by Dr. Safedin Beqaj (Medical Database, Inc.), Dr. Rojeet Shrestha (Patient Choice Laboratories), and Dr. Tim Hamill (University of California, San Francisco), presents an advanced...

Read more
Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300
Healthcare & PharmaceuticalCompany Update

Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300

February 18, 2025 9:00 AM

SAN FRANCISCO, CA / ACCESS Newswire / February 18, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and Jaguar family company Napo Pharmaceuticals ("Napo") today announced that, on January 29, 2025, they extended their collaboration with Streeterville related to Napo's plans to develop its NP-300 drug product candidate for the symptomatic relief of diarrhea and dehydration in cholera patients and pursue a possible Tropical...

Read more
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
Healthcare & PharmaceuticalCompany Update

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

February 18, 2025 8:30 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it will not proceed with an offering pursuant to its Registration Statement on Form S-1 until after filing its...

Read more
Stemtech Corporation: Leading The Global Wellness - Anti-Aging Healthy Revolution
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation: Leading The Global Wellness - Anti-Aging Healthy Revolution

February 18, 2025 8:30 AM

Stemtech Corporation (OTCQB:STEK) is redefining the future of health with its groundbreaking, all-natural, plant-based nutritional stemceuticals™. Stemtech patented products, since 2005, evidence that nature holds the key to unlocking the miraculous potential of stem cells. Stemtech continues to be at the forefront of a massive evolution in the wellness, anti-aging, and longevity sectors.As consumers and the medical community`s awareness of...

Read more
New World Medical Receives 510(k) Clearance for the VIA360(TM) Surgical System, Further Advancing Innovation in Ophthalmic Surgery
Healthcare & PharmaceuticalProduct Announcements

New World Medical Receives 510(k) Clearance for the VIA360(TM) Surgical System, Further Advancing Innovation in Ophthalmic Surgery

February 18, 2025 8:00 AM

New World Medical, a leading innovator in ophthalmic surgical devices, is proud to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VIA360™ Surgical System, for the delivery of controlled amounts of viscoelas­tic fluid during ophthalmic surgeries. The VIA360™, which is also indicated to cut trabecular meshwork tissue during trabeculotomy procedures,1 supports a variety of surgical workflows,...

Read more
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

February 18, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human retinal cell lines. These studies demonstrated the ability of Telomir-1 to significantly reverse copper and iron-induced elevation of Reactive Oxygen Species (ROS).Age-Related Macular Degeneration (AMD) and Current Treatment ChallengesAMD is a leading cause of...

Read more
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators
Healthcare & PharmaceuticalProduct Announcements

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

February 18, 2025 7:15 AM

CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced its recognition as a Top 100 Global Innovator in the Innovation Momentum 2025 report by LexisNexis®. The renowned LexisNexis "Top 100 Global Innovators list" recognized the 100 most dynamic companies worldwide that are driving innovation across their businesses and...

Read more
Global Swab and Viral Transport Medium Market Poised to Reach USD 12,731.1 Million by 2035 to witness CAGR of 2.7% | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Global Swab and Viral Transport Medium Market Poised to Reach USD 12,731.1 Million by 2035 to witness CAGR of 2.7% | Future Market Insights, Inc.

February 18, 2025 4:30 AM

The global swab and viral transport medium market is projected to witness consistent growth over the next decade, reaching approximately USD 9,714.0 million in 2025 and further expanding to nearly USD 12,731.1 million by 2035. The market is set to grow at a steady annual rate of 2.7%, driven by increasing demand for diagnostic testing, advancements in sample collection technologies, and the ongoing emphasis on infectious disease management.In...

Read more
Bioz Badges: Transforming Digital Marketing for Scientific Product Success
Healthcare & PharmaceuticalProduct Announcements

Bioz Badges: Transforming Digital Marketing for Scientific Product Success

February 18, 2025 4:00 AM

Bioz, Inc., a leader in citation management, is revolutionizing digital marketing for suppliers of scientific products through its innovative Bioz Badges. These AI-powered product endorsements are transforming the way suppliers increase product visibility, establish brand credibility, and improve user engagement, ultimately driving higher sales conversions.Bioz Badges are designed to provide researchers with confidence in their purchasing...

Read more
IRLAB Strengthens Its Value Creation Capabilities Through Extended And Expanded Debt Financing
Healthcare & PharmaceuticalRegulatory

IRLAB Strengthens Its Value Creation Capabilities Through Extended And Expanded Debt Financing

February 17, 2025 7:15 PM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the duration of the existing loan from Fenja Capital of SEK 55 million has been extended from May 22, 2025, to June 30, 2026, at the latest. Additionally, the loan can be extended by an extra SEK 20 million under certain conditions. At the same time,...

Read more
MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to Conduct Scientific Research
Healthcare & PharmaceuticalCompany Update

MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to Conduct Scientific Research

February 17, 2025 2:50 PM

MMJ Unwavering Federal Compliance DevelopmentMMJ International Holdings distinguishes itself by adhering strictly to federal regulations at every stage of its R&D process. Rather than cutting corners, the company ensures its FDA clinical trials for its proprietary soft gelatin capsule-blending THC, CBD, and other phytocannabinoids-meet the highest standards set by federal law. This commitment not only minimizes regulatory risks but also enhances...

Read more
Desert Oasis Healthcare Recognized as One of the Best Places to Work for the Seventh Consecutive Year
Healthcare & PharmaceuticalAwards

Desert Oasis Healthcare Recognized as One of the Best Places to Work for the Seventh Consecutive Year

February 17, 2025 1:05 PM

Desert Oasis Healthcare (DOHC) is proud to announce that it has once again earned a spot on the prestigious Fortune Best Workplaces list, marking this the seventh consecutive year the organization has received this honor. This recognition underscores DOHC's unwavering commitment to creating a supportive, inclusive, and safe environment for its employees, providers, and the community it serves.Desert Oasis Healthcare, myself, and the entire...

Read more
Prosmile Completes Acquisition of Neptune Dental Located in New Jersey
Healthcare & PharmaceuticalMergers and Acquisitions

Prosmile Completes Acquisition of Neptune Dental Located in New Jersey

February 17, 2025 12:00 PM

ProSmile(or the "Company"), a leading multi-specialty dental services organization (DSO) and the fastest growing dental organization on the East Coast, announced today the completion of its acquisition of Neptune Dental Care, located in Neptune, New Jersey, on February 5, 2025. This acquisition further strengthens ProSmile's growing presence in New Jersey and complements the Company's rapidly expanding portfolio of dental practices. This move...

Read more
Boomerang Ventures Leads Seed Round in Lizzy Care to Advance AI-Driven At-Home Dementia and Memory Care Solutions
Healthcare & PharmaceuticalFinancing

Boomerang Ventures Leads Seed Round in Lizzy Care to Advance AI-Driven At-Home Dementia and Memory Care Solutions

February 17, 2025 11:15 AM

Boomerang Ventures, a combination venture studio and fund, led a $2.6million Seed funding round for Lizzy Care, a health tech company offering an innovative tech-enabled platform for at-home dementia and memory care. This investment marks Lizzy Care's official addition to Boomerang Ventures' portfolio, reinforcing the firm's commitment to supporting transformative solutions in connected health technologies set to disrupt healthcare for the...

Read more
ASTCT Announces David L. Porter, MD as 2025-2026 President
Healthcare & PharmaceuticalCompany Update

ASTCT Announces David L. Porter, MD as 2025-2026 President

February 17, 2025 10:00 AM

The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce David L. Porter, MD, as the Society's president for the 2025-2026 term. A long-standing leader in the field of transplantation and cellular therapy, Dr. Porter brings decades of experience in research, clinical care, and leadership to ASTCT.Dr. Porter is the Jodi Fisher-Horowitz Professor of Leukemia Care Excellence in the Perelman School of Medicine...

Read more
VOESH Adds New Foot Care to Love with Solemate Heel Repair Balm Lavender
Healthcare & PharmaceuticalCompany Update

VOESH Adds New Foot Care to Love with Solemate Heel Repair Balm Lavender

February 17, 2025 9:05 AM

After the overwhelming success of the Solemate Heel Repair Balm Mint, VOESH New York is thrilled to introduce the latest addition to its foot care lineup: Solemate Heel Repair Balm Lavender. Building on the excitement surrounding the original formula, this new lavender-scented version promises a soothing experience while delivering the same powerful hydration and nourishment for dry, cracked heels.The Solemate Heel Repair Balm Lavender combines...

Read more
DaVita's
Healthcare & PharmaceuticalEnvironmental, Social and Governance

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

February 17, 2025 8:25 AM

DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With Purpose (MIWP) event with more than 8,300 participants, including DaVita teammates, friends, family and key members of the kidney care community. The month-long initiative encourages physical activity - whether it's walking, running, swimming, bicycling or other activities - to benefit Bridge of Life, a nonprofit founded by DaVita to...

Read more
Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins
Healthcare & PharmaceuticalCompany Update

Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins

February 17, 2025 8:00 AM

Leafbuyer Technologies Inc. (OTCQB:LBUY) ("Leafbuyer" or "the Company"), a leading cannabis technology and marketing platform, announced today that quarterly revenue rose 38% year over year in the quarter ending September 30, 2024. The financial data reflects the GAAP revenue booked in the quarter versus the same quarter of the previous year.Kurt Rossner, Chief Executive Officer of Leafbuyer, stated, "The Company continues to gain market share...

Read more
Ecla Clinic Announces Comprehensive Beauty Services in Dubai
Healthcare & PharmaceuticalCompany Update

Ecla Clinic Announces Comprehensive Beauty Services in Dubai

February 17, 2025 8:00 AM

Ecla clinic's team provides various treatments aimed at addressing concerns related to body shape and facial appearance. Their specialists use modern techniques and pay close attention to individual needs, ensuring that each patient's experience reflects a blend of quality care and personal attention. This approach has made Ecla Clinic popular among those seeking results that appear both natural and refined, particularly for clients interested...

Read more
AlzeCure Receives EU Grant for Phase 2 Clinical Trial of NeuroRestore ACD856 for Alzheimer's Disease
Healthcare & PharmaceuticalCompany Update

AlzeCure Receives EU Grant for Phase 2 Clinical Trial of NeuroRestore ACD856 for Alzheimer's Disease

February 17, 2025 4:45 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its project NeuroRestore ACD856 has received €2.5m from the EU's European Innovation Council.This funding will support AlzeCure's planned Phase IIa study of NeuroRestore ACD856 in Alzheimer's patients. In...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?